Your Heart Needs More Than Hope
Every 40 SECONDS, someone in America has a heart attack. Every 36 SECONDS, someone dies from cardiovascular disease. Most never saw it coming because traditional tests missed the real dange
The medical system has failed you. Doctors are trained to wait for blockages but blockages are the final stage of heart disease. By the time you have a 70% blockage, deadly plaque has been silently building for years.
ClearCardio™ exposes what your doctor won't tell you: The $40,000 stents and invasive procedures could have been prevented. Our breakthrough AI technology detects the soft plaque deposits that rupture and cause heart attacks 10-15 years before traditional methods even know there's a problem. We don't just find heart disease, we reverse it, without surgery, without waiting, without the medical system's dangerous "wait and see" approach.
ABOUT CLEAR CARDIO
At ClearCardio™, your heart’s well-being is our focus. Facing the worries of heart health head-on, our team, led by our visionary founder, offers expertise and support for those who take a proactive stance towards their cardiac care.
Our approach is simple yet profound: to ease the burden of concern and empower you with the knowledge and tools to take charge of your heart health.
What sets us apart from everyone else
Advanced AI Technology
Our proprietary imaging detects both calcified and soft plaque that traditional tests completely miss
Precision Diagnosis
We measure plaque volume, density, and composition with 99.9% accuracy
Personalized Treatment
Every patient receives a customized action plan based on their specific plaque profile
Proven Results
Our patients see measurable plaque reduction and risk reversal
Concierge Experience
Premium, personalized care from consultation to follow-up
NOTE: We do not just test for heart disease, we eliminate it. Our non-invasive, 90-minute process gives you complete clarity about your cardiovascular health and a clear roadmap to protect your future.
Truth Matters, Actions Count
Historically 75% of us will develop heart disease. 40% will die.
The 'worried well' are rightly justified in their concerns. This is where ClearCardio™️ steps in—our mission is to bridge the gap between worry and wellness.
By offering comprehensive cardiac assessments, including state-of-the-art cardiac CT and Cleerly™️ AI analysis, we equip you with the knowledge needed to make informed decisions about your health.
ClearCardio™ Pioneers AI in Cardiac Care
Chief Medical Officer
Dr. John Osborne is a highly distinguished cardiologist and the founding director of State of the Heart Cardiology. He earned his B.S. with honors from Penn State University, an M.D. magna cum laude from Jefferson Medical College, and a Ph.D. in cardiovascular physiology from Thomas Jefferson University. Dr. Osborne's postdoctoral work at Harvard Medical School and Brigham and Women’s Hospital laid the groundwork for his expertise in non-invasive cardiology. Uniquely board-certified across multiple disciplines—including Cardiology, Internal Medicine, Lipidology, Clinical Hypertension, Cardiac CT Angiography, Echocardiography, and Nuclear Cardiology—his clinical focus embraces preventive cardiology, metabolic syndrome, and cardiovascular genetics.
Dr. Osborne has been honored with numerous awards, such as the American Heart Association’s Cardiac Care Provider of the Year and has been recognized as a Top Doctor multiple times. His contributions to medical literature are extensive, including original research papers, book chapters, and hundreds of international presentations.
Looking ahead, Dr. Osborne aims to advance the field of cardiology through ongoing research in vascular biology and genetic factors affecting heart disease. He is committed to improving patient outcomes through innovative, non-invasive treatments and continuing to influence the next generation of cardiologists through his roles in national committees and educational initiatives. He is also the founder of ClearCardio™️, an initiative dedicated to enhancing proactive cardiac care and patient empowerment through the introduction of AI technology for disease detection and treatment.
President and Chief Executive Officer
JD Enright, Sr. is a seasoned business leader with over 30 years of experience collaborating with various branches of the U.S. Military, DOD divisions, and agencies such as the CIA and DIA, as well as multinational private and public sector organizations. He has co-founded several technology-based businesses and has occupied senior executive roles focusing on strategic growth initiatives in emerging markets and technologies. Enright has established himself as a key figure in identifying global technology market trends and enhancing business operations to improve financial and operational efficiencies.
At ClearCardio™, he applies his extensive expertise to propel the adoption of innovative technologies such as blockchain and AI, significantly advancing the company's impact in healthcare. His leadership extends to implementing advanced high-performance computing platforms, developing blockchain-based technology strategies, advancing next-generation biotechnologies, and deploying AI for market intelligence assimilation in public healthcare applications
Chief Sales and Marketing Officer
Chief of Sales and Marketing at ClearCardio™, brings over 25 years of entrepreneurial expertise and a profound commitment to health and wellness. Initially, Sherry owned and operated several prosperous brick-and-mortar businesses before transitioning into the digital space in 2016.
Here, she quickly generated over a million dollars in sales with her online nutrition and fitness programs, showcasing her skill in utilizing digital platforms for business growth. As the author of "Your Health is Non-Negotiable," Sherry has significantly influenced the field of women's health, empowering thousands with her educational initiatives.
At ClearCardio™, she leverages her extensive experience to enhance the company’s visibility, develop innovative marketing strategies, and boost customer engagement. Her leadership is pivotal in driving ClearCardio™ toward new achievements in the health sector, ensuring that its services profoundly impact clients’ health journeys.
